| SP (n = 50) | AQ (n = 50) | ||
---|---|---|---|---|
Treatment outcome | TF | ACPR | TF | ACPR |
PCR un-corrected, N (%) | 35 (70) | 15 (30) | 22 (44) | 28 (56) |
PCR corrected, N (%) | 34 (68) | 16 (32) | 19 (38) | 31 (62) |
Median age (months, CI) | 31.5 (25.3–36) | 27.5 (19–41.4) | 24 (19.4–43.9) | 32 (23.5–38.5) |
Females (%) | 31.6 | 38.7 | 41.2 | 68.7 |
Geometric mean parasite density, day0 (/ul. CI) | 39.810 (28.184–56.234)* | 17.865 (8.511–37.153) | 28.840 (14.256–57.544) | 32.359 (22.387–43.651) |
Mean haemoglobin day0 (PCV, SD) | 29.4 (4.8) | 29.6 (5.8) | 28.6 (6.5) | 30.7 (5.1) |
Mean temperature day0 (°C. SD) | 38.8 (0.9) | 38.5 (0.6) | 38.5 (0.9) | 39.1 (0.8) |
Alpha+-thalassaemia, % | 33.4 | 27.6 | 42.9 | 35.7 |
HbAS, % | 15.2 | 12.5 | 10.4 | 9.7 |